Journal
/
Immunology and Infection
/
Utilisant la stratégie capside-Incorporation Antigen pour le développement d'approches adénovirus sérotype 5 Vectored vaccins
JoVE Journal
Immunology and Infection
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Immunology and Infection
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Please note that all translations are automatically generated. Click here for the English version.

Utilisant la stratégie capside-Incorporation Antigen pour le développement d'approches adénovirus sérotype 5 Vectored vaccins

français

Automatically Generated

10,291 Views

•

13:36 min

•

May 06, 2015

DOI:

10.3791/52655-v

DOI:
10.3791/52655-v

•

13:36 min
May 06, 2015

•

2 Views
, , ,
1Department of Medicine,University of Alabama at Birmingham, 2Center for AIDS Research,University of Alabama at Birmingham

Explore More Videos

Adenovirus Serotype 5Ad5Antigen Capsid-incorporation StrategyVaccine DevelopmentHIV EpitopeHis6 TagHexonHypervariable RegionNeutralization AssayHumoral ImmunityRare-serotype Adenovirus

Read Article

Cite this Article

Gu, L., Farrow, A. L., Krendelchtchikov, A., Matthews, Q. L. Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches. J. Vis. Exp. (99), e52655, doi:10.3791/52655 (2015).

Download .ris file

Copy

Share Video

.

Copy